Skip to the reading Semaglutide care A reader’s index The short list The medicine Check a service Visit questions Cost and cover Cautions Sources and results Keep a question. Find an answer. Leave room to think. # Compare the full bill, then the payment route Ask what you will owe for the care as well as the medicine. Keep the regular charge beside any introductory price. ## Ask for the whole bill Care What do visits and messages cost? Tests What is charged if tests are ordered? Medicine Is the medicine included or billed apart? Continuing Which fees repeat, and how do I cancel? Use the same set of questions for each quote. Ask for the usual charge as well as any opening offer. Keep a blank for anything the quote leaves out. Ask whether payment for the visit still applies if no medicine is prescribed. ## Keep a price label beside the figure Semaglutide (Wegovy, Ozempic) has several price labels: a maker’s list figure, an offer for cash payment, or the amount due with insurance. Price reference What the dated figure means Wegovy list price The maker listed about $1,349 for a Wegovy package in the price record dated 26 September 2026. That record does not say how many days the package covers. Ask the pharmacy to put that beside the price before working out a monthly budget. Ozempic list price The same dated price record gives about $1,000 for Ozempic; the maker’s page showed different exact prices for the same products. The record does not give the number of days your pack would cover. Get that and your own price in writing from the pharmacy. Your care quote Ask for your own written total. Include the visit, medicine and any separate charges. These manufacturer list figures describe the medicine, not the total cost of ongoing care. A low headline price leaves questions open: which product does it cover, what are the terms, and what is charged later? ## Ask your insurance plan about the named use Before relying on cover, give the plan the product name and ask about payment for your proposed use. Prior authorization means the prescriber asks the insurer to agree to pay before the medicine is supplied. A formulary is simply the medicine list used by that insurance plan. ### Medicare has a separate temporary route In the rules checked on 26 September 2026, Medicare’s basic Part D drug cover still excludes a use for weight loss alone. Medicare calls its temporary program the GLP-1 Bridge; it operates outside the usual Part D payment route. Its medicine payment is $50 per monthly supply for people who qualify. The recorded end is 31 December 2027; the program opened on 1 July 2026. For semaglutide, that program includes Wegovy tablets and injections; Ozempic for weight loss is outside it. It is not open to everyone on Medicare. You must be at least 18. The plan needs to be either separate Part D drug insurance or a Medicare Advantage plan of the coordinated-care type that includes medicines. Other Medicare plan types need a separate Part D plan for this program. Check the plan type with your insurer before relying on this route. BMI is the height-and-weight measure used here; the program checks it as it stood when treatment began. One of these health routes must fit: Starting BMI Other health condition needed 35 or higher No extra illness is required for this BMI route. 30 or higher One of the following is needed. Heart failure can qualify if it is the type called preserved ejection fraction: the heart’s squeeze remains normal. Kidney disease must have reached at least stage 3a. High blood pressure can qualify if two blood-pressure medicines have not brought the upper reading down to 140 or the lower reading down to 90. 27 or higher One of the following is needed. Prediabetes can qualify. That means raised blood sugar that falls short of a diabetes diagnosis. A previous stroke or heart attack can also qualify. Peripheral artery disease can qualify when it causes symptoms. This means disease of arteries away from the heart. Take the starting weight and height, and the names of your diagnosed illnesses, to the prescriber to check against these routes. The Bridge cannot be used if you have type 2 diabetes. Moderate to severe sleep apnea also excludes a person; that means repeated pauses in breathing while asleep. The same applies to the specific liver illness explained below. Those conditions use ordinary Part D. Prescriptions aimed at reducing the chance of stroke or heart attack also go to that plan. If you received a GLP-1 through Part D during 2026, the Bridge cannot be used for you in 2026. The record had no rule yet for checking past payments in 2027. A prescriber must request approval, with a prescription that includes ongoing food and activity changes. Meeting the weight rule alone does not secure that approval. Government details on the Bridge and who qualifies Ordinary Part D can cover semaglutide for type 2 diabetes, to lower heart attack or stroke risk, or for the liver disease MASH. For Wegovy’s heart use, adults must have heart disease and either obesity or overweight. For its liver use, adults must have MASH, a form of fatty liver disease, with moderate to advanced scarring but without cirrhosis, a severe scarring condition. This does not mean every fatty liver diagnosis rules out the Bridge. The liver approval is conditional, based on improvements in liver samples; a further trial may be needed to keep that approval. Plan payment also needs a check: does its medicine list include this drug, and has it approved this use? Ask the plan which route applies to your prescription and what you would pay. Eligibility still leaves the plan’s payment rules to be checked. Add questions about health problems and help between visits to the cost notes. Read the cautions before a visit This guide offers a place to sort your questions, with no clinic service or medicine checkout. Keep the question sheet Read the evidence